Kenvue

Kenvue in Fortune Rankings

Kenvue is a consumer health company best known for products like Tylenol, Band-Aid, Benadryl, and more. Formerly the consumer health arm of pharma giant Johnson & Johnson, Kenvue spun out from the parent company in August 2023 and operates around the world. The company’s brands are separated into the self-care, skin health and beauty, and essential health segments. Other notable brands that Kenvue operates include Neutrogena, Aveeno, Listerine, and Zyrtec.

Gabby Jones—Bloomberg/Getty Images

Powered by

Updated:6/3/26
Country/Territory:U.S.
Headquarters:Summit, N.J.
Industry:Household and Personal Products
CEO:Kirk L. Perry
Website:https://www.kenvue.com

Ticker:KVUE
Company type:Public
Revenues ($M):$15,124
Profits ($M):$1,470
Market value ($M):$33,045
Number of employees:21,890

Market value as of March 31, 2026.

$ millions% change
Revenues ($M):$15,124-2.1%
Profits ($M):$1,47042.7%
Assets ($M):$27,076-
Total Stockholder Equity ($M):$10,765-

Profit as % of Revenues:9.7%
Profits as % of Assets:5.4%
Profits as % of Stockholder Equity:13.7%

Earnings Per Share ($):0.80
EPS % Change (from prior fiscal year):40.7%
EPS % Change (5 year annual rate):-
EPS % Change (10 year annual rate):-

Total Return to Investors (last year):-16%
Total Return to Investors (5 year, annualized):-
Total Return to Investors (10 year, annualized):-

Kenvue stock chart

Latest news on Kenvue

Hayden Panettiere helped change how women talk about mental health. After her death, consumers aren’t ready to forgive the brand that failed her

Fortune 500 Power Moves: Which executives gained and lost power this week, Nov. 1-7, 2025

‘This team is guided by science’: Kenvue chief hits back at Trump and RFK Jr.’s Tylenol autism claims in memo to 20,000 employees

Tylenol-maker Kenvue’s stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials

Tylenol maker’s stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a ‘major overreaction’

Kenvue in Fortune Rankings

View the Full List